Heble A, et al. - The intent of the authors was to explain the prevalence of SWC with mTOR inhibitor continuation during the perioperative period for major surgeries, in pediatric heart transplant recipients. The findings displayed the possibility of continuing sirolimus in the perioperative period based on the low rate of SWC observed.